About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 139 record(s)
Req # A-2020-001160
Adverse Drug Reactions (ADRs). Report numbers: E2B_02364340, E2B_02364341, E2B_02364386, E2B_02364390, E2B_02364396, E2B_02364426, E2B_02364579, E2B_02364596, E2B_02364674, E2B_02364819, E2B_02367403, E2B_02368215, E2B_02368936, E2B_02369848, E2B_02370010, E2B_02370039, E2B_02370246, E2B_02370402, E2B_02370418, E2B_02371506.Organization: Health Canada
November 2021
Req # A-2020-001164
Adverse Drug Reactions (ADRs). Report numbers: E2B_02358103, E2B_02358302, E2B_02359096, E2B_02359109, E2B_02359111, E2B_02359139, E2B_02359145, E2B_02359156, E2B_02359165, E2B_02359392, E2B_02359907, E2B_02360361, E2B_02361043, E2B_02361855, E2B_02362298, E2B_02363271, E2B_02363764, E2B_02363776, E2B_02363782, E2B_02363815.Organization: Health Canada
November 2021
Req # A-2020-001189
Adverse Drug Reactions (ADRs). Report numbers: E2B_02446272, E2B_02446460, E2B_02446555, E2B 02446706, E2B_02446707, E2B_02446760, E2B_02446818, E2B_02446830, E2B 02447712, E2B_02447721, E2B_02449607, E2B_02449769, E2B_02450180, E2B_02450297, E2B 02450458, E2B_02450523, E2B_02451665, E2B_02452263, E2B_02452549, E2B 02452806.Organization: Health Canada
November 2021
Req # A-2020-001201
Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_02184075.Organization: Health Canada
November 2021
Req # A-2020-001314
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-112028-162.Organization: Health Canada
November 2021
Req # A-2020-001548
Adverse Drug Reactions (ADRs). Report numbers: E2B_03176871, E2B_03176876, E2B_03177152, E2B_03177602, E2B_03178260, E2B_03179248, E2B_03179752, E2B_03179866, E2B_03179927, E2B_03181774, E2B_03182434, E2B_03183669, E2B_03183687, E2B_03183726, E2B_03184847, E2B_03184976, E2B_03185293, E2B_03185389, E2B_03185647, E2B_03186166.Organization: Health Canada
November 2021
Req # A-2020-001571
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115073-825, Minister's Meeting with the Canadian Red Cross - October 28, 2020.Organization: Health Canada
November 2021
Req # A-2020-001585
Adverse Drug Reactions (ADRs). Report numbers: E2B_03313737, E2B_03331464, E2B_03349602.Organization: Health Canada
November 2021
Req # A-2020-001587
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_00679965.Organization: Health Canada
November 2021
Req # A-2020-001595
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03352288.Organization: Health Canada
November 2021